Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-25-018359
Filing Date
2025-05-23
Accepted
2025-05-23 17:24:01
Documents
3
Period of Report
2025-05-23

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A mbrx20250515_pre14a.htm PRE 14A 127944
2 card01.jpg GRAPHIC 194901
3 card02.jpg GRAPHIC 138735
  Complete submission text file 0001437749-25-018359.txt   588480
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37758 | Film No.: 25983515
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)